Chairman, President & CEO of Idexx Laboratories Inc (IDXX, Financial) Jonathan W Ayers sold 30,000 shares of IDXX on 08/23/2018 at an average price of $245.5 a share. The total sale was $7.4 million.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories Inc has a market cap of $21.3 billion; its shares were traded at around $245.97 with a P/E ratio of 71.08 and P/S ratio of 10.33. IDEXX Laboratories Inc had annual average EBITDA growth of 13.80% over the past ten years. GuruFocus rated IDEXX Laboratories Inc the business predictability rank of 5-star.
CEO Recent Trades:
- Chairman, President & CEO Jonathan W Ayers sold 30,000 shares of IDXX stock on 08/23/2018 at the average price of $245.5. The price of the stock has increased by 0.19% since.
Directors and Officers Recent Trades:
- Director Bruce L. Claflin bought 415 shares of IDXX stock on 08/03/2018 at the average price of $242.12. The price of the stock has increased by 1.59% since.
- CORPORATE VICE PRESIDENT Giovani Twigge sold 11,372 shares of IDXX stock on 08/21/2018 at the average price of $242.71. The price of the stock has increased by 1.34% since.
- CVP, Gen. Counsel & Secretary Jacqueline Studer sold 11,619 shares of IDXX stock on 08/21/2018 at the average price of $244.03. The price of the stock has increased by 0.79% since.
- Corporate Vice President Michael Lane sold 5,912 shares of IDXX stock on 08/21/2018 at the average price of $243.78. The price of the stock has increased by 0.9% since.
- CVP, Gen. Counsel & Secretary Jacqueline Studer sold 8,598 shares of IDXX stock on 08/06/2018 at the average price of $242.37. The price of the stock has increased by 1.49% since.
For the complete insider trading history of IDXX, click here
.
